First responders and other rescue and recovery workers following the 2001 World Trade Center (WTC) terrorist attacks received significant dust and pollutant exposures and have developed asthma at twice the rate of the US general population according to new research presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP).

According to a press release, as many as 8% of workers and volunteers participating in the rescue, recovery, and cleanup have developed some sort of asthma episode compared to 4% of the general population. Additionally, only 3% of this workers and volunteers reported asthma pre 9/11, while 16% reported having asthma between 2005 and 2007.

"Although previous WTC studies have shown significant respiratory problems, this is the first study to directly quantify the magnitude of asthma among WTC responders compared with the general US population," said Hyun Kim, ScD, Instructor of Preventive Medicine at Mount Sinai School of Medicine (MSSM), in the press release. "Six years out from 9/11, the World Trade Center Program was still observing responders affected by asthma episodes and attacks at more than double the percentage of people not exposed to World Trade Center dust."

Kalpalatha Guntupalli, MD, FCCP, President of the American College of Chest Physicians commented "Asthma and other chronic lung conditions remain a significant burden for rescue and recovery workers responding to the attacks on the World Trade Center. The significant chronic health problems associated with the World Trade Center attacks only reinforces the need for stronger disaster preparedness plans, as well as long-term medical follow-up for 9/11 responders and individuals who respond to disaster-related events."

What do you think?

With all of the debate over the weekend regarding health-care, I thought it would be interesting to see what ya'll think about payment for asthma medications.

In a previous blog I discussed results from a trial of bronchial thermoplasty, a non-drug treatment where thermal energy is delivered to airways to reduce smooth muscle that narrows airways causing asthma symptoms.

Last week, the Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee to the U.S. Food and Drug Administration (FDA) recommended that the Alair^® System, a device utilized in bronchial thermoplasty for the treatment of severe persistent asthma in patients 18 years and older, was approveable with certain conditions according to a company website.

Clinical trials have demonstrated:

• Significant improvement in quality of life
• 32 percent reduction in severe asthma attacks
• 84 percent reduction in emergency room visits for respiratory symptoms
• 66 percent reduction in days lost from work/school or other activities

"The Advisory Panel's recommendation for approvable with conditions of the Alair^® System marks a major step in bringing this new and important treatment option to patients with severe asthma," said Glen French, CEO of Asthmatx in the press release. "We look forward to working with FDA through the next steps to product approval."

According to the Walmart  Pharmacy Website for their $4 prescription plan, Walmart has a HFA albuterol inhaler for sale for $9. This would be a significant cost reduction compared to currently available rescue inhalers since the CFC to HFA transition.

Have you tried to access this reduced cost inhaler?

Asthma can be very complicated and, at times, difficult to control. Whicj of the following measures do you use to help control your asthma?

Icagen, a biopharmaceutical company focused on the development of drugs that can be taken orally, has announced that it will stop development of its novel, oral asthma medication senicapoc after a clinical trial failed to deliver anticipated benefits.

Senicapoc initally demonstrated promise in animal studies where it was effective in treating the late phase of asthma. Seth V. Hetherington, M.D., SVP of Clinical Development and Regulatory Affairs of Icagen discussed the results of the senicapoc clinical trials stating in a press release stating that "we completed two small, cost-effective, proof-of-concept clinical studies testing the potential of senicapoc in the treatment of asthma. While we were encouraged by the results in our first study of allergic asthma, we were disappointed by the lack of effects in this second study of exercise-induced asthma."

An oral asthma medication in addition to currently available leukotriene modifers like Singulair, theophyillne, and oral steroids would be welcome by both patients and parents due to ease of administration compared to inhalers. What do you think?

More than 1 in 3 patients referred to a specialty asthma clinic for poorly controlled asthma did not fill inhaled steroid prescriptions appropriately more than 50% of the time according to a study published in the American Journal of Respiratory and Critical Care Medicine.

Interestingly, none of the patients were suspected by the doctors as non-compliant prior to their referral and none of the patients admitted non-compliance as the reason for their poorly controlled asthma. Non-compliance was discovered in reviewing pharmacy records in a single payer system of health care.

Medication compliance is not a one size fits all problem. Some patients have concerns about side effects and other patients have difficulties in obtaining medications. What is painfully clear from this study is that many asthmatics, even ones with really poorly controlled asthma, are not doing a good job of taking medications that are known to be beneficial.

What do you think? Why do poorly controlled asthmatics have a hard time being compliant? What do you think we can do better? Leave a comment and let the asthma community know what you think.

According to the the American Academy of Allergy, Asthma & Immunology (AAAAI), food allergy patients are not the only ones who need to be mindful at Halloween. While it makes sense parents of food allergy patients need to be mindful of treats this weekend, holidays like Halloween may worsen your child's asthma. The AAAAI offers these suggestions in a press release to help keep your child's asthma under control:

• Watch out for costumes- If you have stored costumes in an attic or closet be mindful of dust and molds. Make sure to throughly clean before using.
• Don't let your kids enter homes while trick or treating- Unknown pets or smoke may trigger asthma.
• Weather- If weather is one of your child's triggers, make sure to carefully check out the forecast and dress appropriately.
• If your child is sick- While it may not be a popular decision, not trick or treating may be the best thing if your child is sick this Halloween.
• Be prepared- Make sure you trick or treat with an asthma inhaler in case your child's asthma does worsen this Halloween.

Increasingly asthmatics are trying alternative asthma treatments. Have you ever tried one of these treatments?

Why not go to our forum and give us your experience with alternative asthma treatments.

According to a press release from the American Academy of Allergy, Asthma & Immunology, data released from the Centers for Disease Control estimates that 26% of 1400 adults hospitalized for the H1N1 swine flu were asthma patients. As a result, a soon to be published article in the The Journal of Allergy and Clinical Immunology will recommend that all patients with asthma who either have the flu or are suspected of having the flu should be considered for antiviral treatments like TamiFlu.

With the increased risk of pneumonia and other complications among asthmatic patients contracting the flu, it is important to learn as much as you can to prevent flu.

Learn More

• 3 Steps to Prevent Flu
• Why Do I Need a Flu Vaccine?
• Flu Vaccine Myths
=======================
Stay up to date: subscribe to
the Asthma newsletter and join the
discussion in the Asthma forum.
Follow me on Twitter
=======================